LRINEC Score for Necrotizing Soft Tissue Infection
LRINEC Score: Uses routine laboratory values to help identify patients at higher risk for necrotizing soft‑tissue infection.
Indications for Use
Used in adults with suspected necrotizing soft‑tissue infection to support (not replace) clinical judgment by identifying patients at higher risk who may need immediate surgical evaluation. Diagnostic utility is limited: meta‑analysis shows poor sensitivity (LRINEC ≥6 sensitivity 68.2%, specificity 84.8%) 1 [Level I evidence], so it cannot rule out NSTI. Best used as an adjunct to clinical assessment and imaging when suspicion exists.
Insights & Cautions
Carries poor sensitivity and cannot rule out NSTI; meta‑analysis shows sensitivity only 68% for ≥6 and 41% for ≥8 1 [Level I evidence]. High false negatives confirmed in prospective validation (sensitivity 43% for ≥6) 2 [Level II evidence]. Should be used only as an adjunct, never to delay early surgical consultation. Performance worsens in certain cohorts (e.g., PWID) 3 [Level II evidence].